March 01, 2015 10:33 AM ET

Capital Markets

Company Overview of Biotechonomy

Company Overview

Biotechonomy is a life science venture capital firm specializing in start-up and early stage entrepreneurial companies. The firm typically invests in companies in genomics-based energy, industrial and agricultural opportunities; companies with technologies that accelerate drug discovery and development; and businesses capable of improving the diagnosis and treatment of disease sectors. Biotechonomy is based in Boston, Massachusetts.

, MA 

United States

Key Executives for Biotechonomy

Chief Executive Officer and Chairman
Age: 54
Principal
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Valdés & Moreno, Inc. United States
National Capital Securities, Inc. United States
Czech Connection, Inc. United States
EBIT Associates, Ltd. United States
Zeta Acquisition Corp. II United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 21, 2014
New Matter, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biotechonomy, please visit biotechonomy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.